We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 13th:
American Equity Investment Life Holding Company (AEL - Free Report) : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.
American Equity Investment Life Holding Company Price and Consensus
American Equity Investment Life has a price-to-earnings ratio (P/E) of 5.26, compared with 11.20 for the industry. The company possesses a Value Score of A.
American Equity Investment Life Holding Company PE Ratio (TTM)
Navios Maritime Partners L.P. (NMM - Free Report) : This company that owns and operates dry cargo vessels has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 29.5% over the last 60 days.
Bausch Health Companies Inc. (BHC - Free Report) : This company that develops, manufactures, and markets a range of pharmaceutical, medical device in the therapeutic areas of eye health, gastroenterology, and dermatology has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.1% over the last 60 days.
Office Depot, Inc. (ODP - Free Report) : This company that provides business services and supplies, products, and technology solutions has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.4% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Value Stocks to Buy for December 13
Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 13th:
American Equity Investment Life Holding Company (AEL - Free Report) : This provider of life insurance products and services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 39.1% over the last 60 days.
American Equity Investment Life Holding Company Price and Consensus
American Equity Investment Life Holding Company price-consensus-chart | American Equity Investment Life Holding Company Quote
American Equity Investment Life has a price-to-earnings ratio (P/E) of 5.26, compared with 11.20 for the industry. The company possesses a Value Score of A.
American Equity Investment Life Holding Company PE Ratio (TTM)
American Equity Investment Life Holding Company pe-ratio-ttm | American Equity Investment Life Holding Company Quote
Navios Maritime Partners L.P. (NMM - Free Report) : This company that owns and operates dry cargo vessels has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 29.5% over the last 60 days.
Navios Maritime Partners LP Price and Consensus
Navios Maritime Partners LP price-consensus-chart | Navios Maritime Partners LP Quote
Navios Maritime Partners has a price-to-earnings ratio (P/E) of 6.72, compared with 20.50 for the industry. The company possesses a Value Score of A.
Navios Maritime Partners LP PE Ratio (TTM)
Navios Maritime Partners LP pe-ratio-ttm | Navios Maritime Partners LP Quote
Bausch Health Companies Inc. (BHC - Free Report) : This company that develops, manufactures, and markets a range of pharmaceutical, medical device in the therapeutic areas of eye health, gastroenterology, and dermatology has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.1% over the last 60 days.
Bausch Health Cos Inc. Price and Consensus
Bausch Health Cos Inc. price-consensus-chart | Bausch Health Cos Inc. Quote
Bausch Health has a price-to-earnings ratio (P/E) of 6.73, compared with 16.00 for the industry. The company possesses a Value Score of A.
Bausch Health Cos Inc. PE Ratio (TTM)
Bausch Health Cos Inc. pe-ratio-ttm | Bausch Health Cos Inc. Quote
Office Depot, Inc. (ODP - Free Report) : This company that provides business services and supplies, products, and technology solutions has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.4% over the last 60 days.
Office Depot, Inc. Price and Consensus
Office Depot, Inc. price-consensus-chart | Office Depot, Inc. Quote
Office Depot has a price-to-earnings ratio (P/E) of 5.90, compared with 8.10 for the industry. The company possesses a Value Score of A.
Office Depot, Inc. PE Ratio (TTM)
Office Depot, Inc. pe-ratio-ttm | Office Depot, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>